135 related articles for article (PubMed ID: 23748831)
1. A case report of a patient with advanced acinar cell carcinoma of the pancreas: long-term survival with regional, systemic and targeted therapy.
Ang C; Herran LA; Lagunes DR; Klimstra DS; Kemeny NE
Tumori; 2013; 99(2):e61-4. PubMed ID: 23748831
[TBL] [Abstract][Full Text] [Related]
2. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report.
Schempf U; Sipos B; König C; Malek NP; Bitzer M; Plentz RR
Z Gastroenterol; 2014 Feb; 52(2):200-3. PubMed ID: 24526405
[TBL] [Abstract][Full Text] [Related]
3. FOLFOX regimen in pancreatic acinar cell carcinoma: case report and review of the literature.
Simon M; Bioulac-Sage P; Trillaud H; Blanc JF
Acta Oncol; 2012 Mar; 51(3):403-5. PubMed ID: 21961498
[No Abstract] [Full Text] [Related]
4. Pancreatic acinar cell carcinoma with bilateral ovarian metastases, panniculitis and polyarthritis treated with FOLFIRINOX chemotherapy regimen. A case report and review of the literature.
Callata-Carhuapoma HR; Pato Cour E; Garcia-Paredes B; Fernandez RM; Mendoza Fernandez ML; Fernandez AM; De La Rosa CA; Sotelo Lezama MJ; Cabezas-Camarero S; Sastre Varela J
Pancreatology; 2015; 15(4):440-4. PubMed ID: 25959244
[TBL] [Abstract][Full Text] [Related]
5. Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report.
Toyama Y; Ushigome T; Watanabe K; Kitamura H; Onda S; Saito R; Yoshida S; Kawahara H; Yanagisawa S; Yanaga K
World J Surg Oncol; 2012 Jun; 10():129. PubMed ID: 22747970
[TBL] [Abstract][Full Text] [Related]
6. Metastatic acinar cell carcinoma of the pancreas responding to gemcitabine, 5-fluorouracil and leucovorin therapy: a case report.
Sorscher SM
Eur J Cancer Care (Engl); 2009 May; 18(3):318-9. PubMed ID: 19445023
[TBL] [Abstract][Full Text] [Related]
7. [Systemic therapy for colorectal cancer].
Pestalozzi BC; Jäger D; Knuth A
Chirurg; 2005 Jun; 76(6):570-2, 574. PubMed ID: 15905968
[TBL] [Abstract][Full Text] [Related]
8. Liver resection following FOLFOXIRI plus bevacizumab: a detailed pathological review.
Walter H; Thomas AL
Br J Cancer; 2013 Jun; 108(12):2417-8. PubMed ID: 23801031
[No Abstract] [Full Text] [Related]
9. Preoperative Treatment With FOLFIRINOX and Successful Resection for a Patient With Mixed Acinar-Endocrine Carcinoma of the Pancreas.
Sugimoto M; Hines OJ; Dawson DW; Muthusamy VR; Reber HA; Donahue TR
Pancreas; 2017 Apr; 46(4):e32-e34. PubMed ID: 28291165
[No Abstract] [Full Text] [Related]
10. Oncological management of unresectable liver metastases.
Prenen H; Van Cutsem E
Dig Dis; 2012; 30 Suppl 2():137-42. PubMed ID: 23207946
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
12. Always look at the bright side of drugs?
Nygren P
Acta Oncol; 2015 Feb; 54(2):145-7. PubMed ID: 25608927
[No Abstract] [Full Text] [Related]
13. First description of an uterine perforation potentially imputable to treatment with bevacizumab.
Uguen T; Leconte B; Desgrippes R; Tchoundeu B; Bretagne JF; Manfredi S
Acta Oncol; 2012 Nov; 51(8):1102-4. PubMed ID: 23020310
[No Abstract] [Full Text] [Related]
14. [A case of liver metastasis of mixed acinar-endocrine carcinoma treated with various loco-regional cancer therapies].
Nishii T; Amano R; Nakao S; Doi Y; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2126-8. PubMed ID: 19106545
[TBL] [Abstract][Full Text] [Related]
15. Perforating dermatosis in a patient receiving bevacizumab.
Vano-Galvan S; Moreno C; Medina J; Pérez-García B; García-López JL; Jaén P
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):972-4. PubMed ID: 19470057
[No Abstract] [Full Text] [Related]
16. Locally advanced anaplastic pancreatic adenocarcinoma with initial response to FOLFIRINOX and rapid progression after five months.
Shinagare AB; Ramaiya NH; Bellizzi AM; Mayer RJ
Pancreatology; 2012; 12(1):35-8. PubMed ID: 22487471
[TBL] [Abstract][Full Text] [Related]
17. Selecting regimens in advanced colon cancer.
Diasio RB
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-19-24. PubMed ID: 23570094
[No Abstract] [Full Text] [Related]
18. Effective intra-arterial chemotherapy for acinar cell carcinoma of the pancreas.
Ukei T; Okagawa K; Uemura Y; Miyauchi K; Kaneko T; Mizunoya S; Monden M
Dig Surg; 1999; 16(1):76-9. PubMed ID: 9949272
[TBL] [Abstract][Full Text] [Related]
19. Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report).
Sawai K; Goi T; Koneri K; Katayama K; Yamaguchi A
World J Surg Oncol; 2013 Aug; 11(1):203. PubMed ID: 23957924
[TBL] [Abstract][Full Text] [Related]
20. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Eur J Surg Oncol; 2015 Jul; 41(7):868-74. PubMed ID: 25865557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
